We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Ferroptosis: a new hunter of hepatocellular carcinoma

    Ferroptosis is an iron ion-dependent, regulatory cell death modality driven by intracellular lipid peroxidation that plays a key role in the...

    Yulang Jiang, Yongxin Yu, ... Mingyu Sun in Cell Death Discovery
    Article Open access 13 March 2024
  2. Risk prediction for dermatomyositis-associated hepatocellular carcinoma

    Objective

    To explore dermatomyositis signature genes as potential biomarkers of hepatocellular carcinoma and their associated molecular regulatory...

    Xusheng Zhang, Yongxin Ma, ... Bendong Chen in BMC Bioinformatics
    Article Open access 31 May 2023
  3. β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression

    To explore the effects of β-Sitosterol upon hepatocellular carcinoma cell proliferation, apoptosis, migration, invasion, and epithelial–mesenchymal...

    Ruoyu Wang, Dan Tang, ... Xuefei Tian in Human Cell
    Article Open access 30 May 2024
  4. Kinesin family member 11 promotes progression of hepatocellular carcinoma via the OCT4 pathway

    Hepatocellular carcinoma (HCC) is the tumor with the second highest mortality rate worldwide. Recent research data show that KIF11, a member of the...

    Ju Zhang, Zuxing Wei, ... Kuijie Liu in Functional & Integrative Genomics
    Article 30 August 2023
  5. Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3

    Background

    Hepatocellular carcinoma (HCC) is a common cancer worldwide, and sorafenib is a first-line drug for the treatment of advanced liver cancer....

    Zongqiang Hu, Yingpeng Zhao, ... Shengning Zhang in Molecular Biology Reports
    Article Open access 16 June 2023
  6. MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma

    Hepatocellular carcinoma is a primary liver cancer, characterised by diverse etiology, late diagnoses, and poor prognosis. Hepatocellular carcinoma...

    Olaniyi Olarewaju, Yuhai Hu, ... Asha Balakrishnan in Cell Death & Disease
    Article Open access 27 June 2024
  7. USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis

    Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. The Hippo signaling pathway has emerged as a significant suppressive...

    Dongyi Liu, Quanhui Li, ... Yinlu Ding in Cell Death & Disease
    Article Open access 12 April 2023
  8. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20

    Angiogenesis plays an essential role in the microenvironment of hepatocellular carcinoma (HCC). HOXD3 is involved in the metastasis and invasion of...

    Lumin Wang, Chenyang Qiao, ... **hai Wang in Cell Death & Disease
    Article Open access 16 March 2024
  9. LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients

    Background

    Invasion and metastasis of hepatocellular carcinoma (HCC) is still an important reason for poor prognosis. LincRNA ZNF529-AS1 is a recently...

    Yang Ma, Wan-liang Sun, ... Dengyong Zhang in BMC Bioinformatics
    Article Open access 17 February 2023
  10. Ferroptosis: a new promising target for hepatocellular carcinoma therapy

    Hepatocellular carcinoma (HCC) is the sixed most common malignant tumor in the world. The study for HCC is mired in the predicament confronted with...

    Qiao** Xu, Lanqi Ren, ... Gang Wang in Molecular and Cellular Biochemistry
    Article 05 December 2023
  11. Exploring the Prognostic Features of Hepatocellular Carcinoma via Text Mining and Data Analysis

    Abstract

    Transcatheter arterial chemoembolization is one of the interventional treatments for hepatocellular carcinoma (HCC). This treatment is...

    Z. H. Yang, S. X. Wang in Molecular Biology
    Article 03 March 2023
  12. Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients

    Hepatocellular carcinoma (HCC) stands as the most common cancer type, arising from various causes, and responsible for a substantial number of...

    Niamat Ullah Khan, Asma Sadiq, ... Gezahign Fentahun Wondmie in AMB Express
    Article Open access 25 April 2024
  13. ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma

    Zinc finger protein 281 (ZNF281) has been shown to promote tumor progression. However, the underlying mechanism remains to be further elucidated. In...

    Qingfang Zhao, Chenguang Zhang, ... Wei Ding in Cell Death Discovery
    Article Open access 25 October 2023
  14. A Symbolic Regression Approach to Hepatocellular Carcinoma Diagnosis Using Hypermethylated CpG Islands in Circulating Cell-Free DNA

    Hepatocellular carcinoma is the most common primary liver cancer, accounting for 90% of cases, and a major cause of death worldwide. Despite this,...
    Conference paper 2023
  15. AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation

    The dependence of hepatocellular carcinoma (HCC) cells on glutamine suggests the feasibility of targeting glutamine metabolism for therapy. However,...

    Yan Liu, Zeyu Miao, Qing Yang in Cell Biochemistry and Biophysics
    Article 24 May 2024
  16. Ubiquitination-specific protease 7 enhances stemness of hepatocellular carcinoma by stabilizing basic transcription factor 3

    This study aims to explore the molecular regulation mechanism of ubiquitination-specific protease 7 (USP7) in facilitating the stemness properties of...

    Mingchao Hu, Chengchen Dai, ... Wenjie Zheng in Functional & Integrative Genomics
    Article 10 February 2024
  17. Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth

    Hepatocellular carcinoma (HCC) is the second lethal cancer. Short overall survival, low five-year survival rate, and unimproved treatment efficacy...

    Mai Ly Thi Nguyen, Chi Pham, ... Khac Cuong Bui in Cell Biochemistry and Biophysics
    Article 20 January 2024
  18. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma

    Long non-coding RNAs (lncRNAs) have been implicated in carcinogenesis and progression of hepatocellular carcinoma (HCC). This study aimed to identify...

    Huiyuan Qiu, Bo Jiang, ... **aolei Cao in Journal of Applied Genetics
    Article 12 February 2024
  19. Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches

    Hepatocellular carcinoma (HCC) is a primary liver malignancy that accounts for the majority of liver cancer cases, with multiple risk factors...
    Yelda Yüregir, Demet Kaçaroğlu, Seher Yaylacı in Cell Biology and Translational Medicine, Volume 21
    Chapter 2023
  20. Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma

    Hepatocellular carcinoma (HCC), with its high mortality and short survival rate, continues to be one of the deadliest malignancies despite relentless...

    Abdulhakim Umar Toro, Sudheesh K. Shukla, Parveen Bansal in Molecular Biology Reports
    Article 07 July 2023
Did you find what you were looking for? Share feedback.